President Trump Unveils Opioid Plan, NACDS Affirms Role in Solution NACDS urges policy recommendations based on pharmacists’ insights, experiences
NACDS urges policy recommendations based on pharmacists’ insights, experiences.
NACDS urges policy recommendations based on pharmacists’ insights, experiences.
Record-setting NACDS RxIMPACT Day on Capitol Hill provides ideal venue for grassroots, political honors.
At the invitation of The White House, NACDS participated in today’s White House Opioid Summit that featured the involvement of President Donald Trump, First Lady Melania Trump, and members of the President’s Cabinet.
U.S. Sens. Michael Bennet (D-CO) and Dean Heller (R-NV) introduced the bill in the Senate on February 27, with the original cosponsorship of U.S. Sens. Elizabeth Warren (D-MA) and Pat Toomey (R-PA).
For the first time in the event's 10-year history, pharmacy advocates from all 50 states are coming to Washington, D.C., and they will reach the office of every member of the U.S. Congress.
Two sustainability awards recognize NACDS’ commitment to addressing commuter issues for the staff team and for the community.
Alex Gourlay, NACDS Chairman of the Board and co-chief operating officer, Walgreens Boots Alliance and president, Walgreen Co., said, “Pharmacy is beautifully positioned, as it always has been, to take care of changing shifts in the customer and in the marketplace."
The certificate program trains and educates pharmacists on providing innovative pharmacy services for patients.
In its sixth year, the program fosters vital pharmacy-based patient care research among faculty at U.S. schools and colleges of pharmacy.
Columnist, author, political analyst and former presidential speechwriter known for capturing “shared virtues of Americans” will speak at Sunday Business Program.